:quality(75)/cdn.jwplayer.com/v2/media/V6yMsk03/poster.jpg)
OMS recomienda el antiviral de Pfizer para tratar a pacientes de COVID-19
La OMS recomendó el viernes el uso del antiviral paxlovid del laboratorio estadounidense Pfizer para los pacientes de covid-19 con síntomas poco severos pero con “mayor riesgo de hospitalización”. (Fuente: AFP)
- Redacción Ojo
- 23 de abril de 2022 07:24 p. m.
- Duración: 01:42
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FTUOKFFWSVCN5ITPBNM7VF4PHU.png)
:quality(75)/cdn.jwplayer.com/v2/media/HZ3hfESM/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yUicB3lY/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ORJhyEs3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ldbCVOoi/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/KOJ2QFC335GVLAAPQM75USP6NY.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DSFFSXHXIJFY7G2SCWAO7H2YYM.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/VNKELAZWXBHNPDM337JKUASCAU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/7PVAK2KSTFHZLH6PZPL2HFEMKQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JPXE34LRHRFQ5GMBVW4I2VWNHQ.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/xhojB3zG/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/7xdUIehY/poster.jpg)